
浏览全部资源
扫码关注微信
河南中医药大学,郑州 450000
琚保军,副教授,副主任医师,硕士生导师,从事中医药防治男科疾病的研究,E-mail:7743857@qq.com
王祖龙,教授,主任医师,博士生导师,从事中医药防治男科疾病的研究,E-mail:zhpanpan1992@126.com
收稿日期:2022-10-20,
网络出版日期:2023-02-01,
纸质出版日期:2023-05-05
移动端阅览
琚保军,王祖龙.龙倍散神阙穴贴敷联合中药辨证口服治疗早泄的临床疗效分析[J].中国实验方剂学杂志,2023,29(09):196-201.
JU Baojun,WANG Zulong.Clinical Efficacy of Longbeisan Application at Shenque (CV 8) Combined with Oral Administration of Chinese Medicine in Treatment of Premature Ejaculation[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(09):196-201.
琚保军,王祖龙.龙倍散神阙穴贴敷联合中药辨证口服治疗早泄的临床疗效分析[J].中国实验方剂学杂志,2023,29(09):196-201. DOI: 10.13422/j.cnki.syfjx.20231497.
JU Baojun,WANG Zulong.Clinical Efficacy of Longbeisan Application at Shenque (CV 8) Combined with Oral Administration of Chinese Medicine in Treatment of Premature Ejaculation[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(09):196-201. DOI: 10.13422/j.cnki.syfjx.20231497.
目的
2
探讨龙倍散神阙穴贴敷联合中药辨证口服对早泄(PE)的临床价值。
方法
2
选取98例同期在河南中医药大学第一附属医院男科就诊的PE患者,随机分为观察组和对照组,每组49例,观察组采用龙倍散神阙穴贴敷联合中药辨证口服治疗,对照组采用盐酸达泊西汀片治疗,治疗8周。观察并对比2组患者阴道内射精潜伏期(IELT)、中国早泄患者性功能评价表-5(CIPE-5)评分、患者性生活满意度、配偶性生活满意度及有效率和不良事件发生率。
结果
2
治疗结束后,观察组总有效率为85.71%(42/49),对照组总有效率为67.35%(33/49),观察组明显优于对照组,差异有统计学意义(
χ
2
=6.262,
P
<
0.05)。与本组治疗前比较,两组患者IELT、CIPE-5评分、患者及配偶满意度评分均显著升高(
P
<
0.01)。与对照组治疗后比较,观察组患者IELT、CIPE-5评分、患者及配偶满意度评分均明显升高(
P
<
0.05,
P
<
0.01)。观察组临床疗效优于对照组。治疗期间,对照组患者出现7例(7/49,14.29%)不良反应,观察组患者出现2例(2/49,4.08%)不良反应,观察组安全性优于对照组(
χ
2
=9.000,
P
<
0.05)。随访评价中,对照组患者出现11例(11/49,22.45%)症状加重,治疗组患者出现3例(3/49,6.12%)症状加重,观察组具有更好的持久作用(
χ
2
=0.317,
P
<
0.05)。
结论
2
龙倍散神阙穴贴敷联合中药辨证口服治疗PE与盐酸达泊西汀相比,可以获得更好的临床效果,且具有更强的安全性和远期疗效。
Objective
2
To investigate the clinical value of Longbeisan application at Shenque (CV 8) combined with oral administration of Chinese medicine in the treatment of premature ejaculation (PE).
Method
2
A total of 98 PE patients treated in the andrology department of the First Affiliated Hospital of Henan University of Chinese Medicine at the same time period were randomly assigned into an observation group and a control group, with 49 patients in each group. The observation group received Longbeisan application at Shenque (CV 8) combined with oral treatment of Chinese medicine according to syndrome differentiation, and the control group was treated with dapoxetine hydrochloride tablets. The treatment in both groups lasted for 8 weeks. The intravaginal ejaculatory latency time (IELT), Chinese index of premature ejaculation-5 (CIPE-5) score, patient's sexual life satisfaction, spouse's sexual life satisfaction, effective rate, and adverse reaction incidence were compared between the two groups.
Result
2
After treatment, the observation group had higher total effective rate than the control group [(85.71% (42/49) vs. 67.35% (33/49),
χ
2
=6.262,
P
<
0.05]. The IELT, CIPE-5 score, and patient's and spouse's satisfaction scores after treatment increased compared with those before treatment (
P
<
0.01), and the increases were more significant in the observation group (
P
<
0.05,
P
<
0.01). The clinical effect of the observation group was better than that of the control group. During the treatment, 7 (7/49,14.29%) patients in the control group and 2 ,2/49,4.08%) patients in the observation group showed adverse reactions, which indicated the safety of the observation group was better than that of the control group (
χ
2
=9.000,
P
<
0.05). In the follow-up period, 11 (11/49,22.45%) patients in the control group and 3 (3/49,6.12%) patients in the observation group showed aggravation of symptoms, which meant that the observation group had better lasting effect (
χ
2
=0.317,
P
<
0.05).
Conclusion
2
Longbeisan application at Shenque (CV 8) combined with oral administration of Chinese medicine has better clinical effect, stronger safety, and longer effect than dapoxetine hydrochloride in the treatment of PE.
张磊 , 高明 , 孟平 , 等 . 早泄发生机制的影像学研究进展 [J]. 现代泌尿外科杂志 , 2020 , 25 ( 7 ): 644 - 647 .
张建中 , 李宏军 . 早泄的临床流行病学研究进展 [J]. 中国男科学杂志 , 2020 , 34 ( 4 ): 71 .
景冠华 . 早泄诊断客观指标的研究进展 [J]. 中华男科学杂志 , 2019 , 25 ( 2 ): 164 - 167 .
杨锐林 , 李展翔 , 叶旭莹 , 等 .“ 夫妻同治、身心同治”理念下“递进式”行为疗法联合药物治疗早泄的临床研究 [J]. 中国性科学 , 2020 , 29 ( 6 ): 13 - 17 .
朱庆文 . 中医外治发展的几个关键问题探讨 [J]. 中医外治杂志 , 2010 , 19 ( 1 ): 3 - 5 .
兰雨泽 , 吉红玉 , 朱向东 , 等 . 龙骨的临床应用及其用量探究 [J]. 吉林中医药 , 2019 , 39 ( 12 ): 1579 - 1582 .
中国中医药信息学会男科分会 . 早泄中西医结合多学科诊疗指南(2021版) [J]. 中国男科学杂志 , 2021 , 35 ( 3 ): 66 - 72 .
张春影 , 李兴华 , 袁谭 , 等 . 阴茎背神经局部解剖学研究及其临床意义 [J]. 中华男科学杂志 , 2009 , 15 ( 2 ): 130 - 133 .
YUAN Y M , XIN Z C , JIANG H , et al . Sexual function of premature ejaculation patients assayed with Chinese index of premature ejaculation [J]. Asian J Androl , 2004 , 6 ( 2 ): 121 - 126 .
BURNETT A L . Commentary RE:The international index of erectile function (IIEF):A multidimensional scale for assessment of erectile dysfunction [J]. Urology , 2020 , 145 : 308 - 309 .
张建中 , 李宏军 . 早泄治疗的新进展 [J]. 中华男科学杂志 , 2018 , 24 ( 10 ): 933 - 936 .
JANSSEN P K , ZWINDERMAN A H , OLIVIER B , et al . Serotonin transporter promoter region (5-HTTLPR) polymorphism is not associated with paroxetine-induced ejaculation delay in dutch men with lifelong premature ejaculation [J]. Korean J Urol , 2014 , 55 ( 2 ): 129 - 133 .
莫敦胜 . 5型磷酸二酯酶抑制剂治疗早泄的研究进展 [J]. 中华男科学杂志 , 2015 , 21 ( 6 ): 561 - 565 .
宋博 , 侯震晖 , 刘群龙 , 等 . 采用阴茎系带延长治疗早泄的临床研究 [J]. 中华男科学杂志 , 2015 , 21 ( 2 ): 149 - 152 .
DOGAN S , DOGAN M . The frequency of sexual dysfunctions in male partners of women with vaginismus in a Turkish sample [J]. Int J Impot Res , 2008 , 20 ( 2 ): 218 - 221 .
张弓 , 林晓峰 . 早泄的中医辨治综述 [J]. 黑龙江中医药 , 2013 , 42 ( 1 ): 64 - 65 .
李曰庆 , 李海松 , 孙永章 , 等 . 中医药治疗男科领域临床优势病种的探讨 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 12 ): 182 - 188 .
国家药典委员会 . 中华人民共和国药典:一部 [M]. 北京 : 中国医药科技出版社 , 2015 : 67 , 120 .
郭俊含 , 陈莉莉 , 张晓萌 , 等 . 五倍子的药理作用及研究进展 [J]. 科学技术创新 , 2019 ( 2 ): 49 - 50 .
康大力 , 瞿融 , 朱维莉 , 等 . 柴胡加龙骨牡蛎汤有效部位抗抑郁作用机制研究 [J]. 中国实验方剂学杂志 , 2011 , 17 ( 1 ): 138 - 141 .
孙培军 , 董一 , 焦玉娟 . 温经汤联合自制温宫贴穴位贴敷治疗寒凝血瘀型原发性痛经临床疗效观察 [J]. 世界中西医结合杂志 , 2021 , 16 ( 4 ): 696 - 699 .
孙菲菲 , 何佳 . 温针灸结合艾灸神阙穴治疗寒凝血瘀型原发性痛经的效果及对痛经症状、前列腺素、 β -EP水平的影响 [J]. 临床医学研究与实践 , 2022 , 7 ( 14 ): 126 - 129,134 .
0
浏览量
32
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621